Work

NCCTG phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.4113

Authors: G. P. Kim, A. Oberg, B. Kabat, A. Sing, E. Hedrick, D. Campbell, S. Alberts

Institutions: Genentech, North Central Cancer Treatment Group, Sanofi (United States)

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2206443486

Cites:

Cited by: 18

Related to: 10